Screening for non-communicable diseases

D. M. Christe, S. Vijaya, K. Tharangini


Background: This study was conducted to enumerate the results of screening for non-communicable diseases in the NCD clinic over a period of one year in a tertiary health centre.

Methods: The results from screening tests conducted in the NCD clinic, for detecting hypertension, diabetes mellitus, breast cancer and cervical cancer, in Government tertiary care Hospital for Women, Chennai, were recorded. The flowchart and screening methods followed were those recommended by the NHM - NPCDCS. Data thus obtained was analyzed using standard statistical methods.

Results: Of 42,519 women screened for common non communicable diseases - hypertension, diabetes mellitus, breast cancer and cervical cancer, nearly 5.55% women (n = 2359) had positive results, for any one of the diseases screened. Of 11,708 women screened for diabetes mellitus and 13,971 screened for hypertension, positive results were found in 856 women and 1,216 women respectively. Around 7,568 women were screened for cervical cancer and 175 women tested positive. A large number of 9,272 women were screened for breast cancer and 112 women had positive results. As per the guidelines, women who tested positive for screening tests were referred to the concerned departments in RGGGH.

Conclusions: Nearly 42,519 women were screened for common non-communicable diseases (NCDs) - hypertension, diabetes mellitus, breast cancer and cervical cancer, and 5.55% women had positive test results for any one of the diseases screened. The screening revealed, 8.7% of women had raised blood pressure, 7.31% had raised blood sugar levels, 1.21% women had positive screening test results for breast cancer, and 2.31% women for cervical cancer.


Breast cancer, Cervical cancer, Diabetes mellitus, Hypertension, Non communicable diseases

Full Text:



Thakur JS, Raina N, Karna P, Singh P, Jeet G, Jaswal N. Overview of national strategies on non-communicable disease and adolescent health in South-East Asia Region countries. Int J Non-Commun Dis. 2016;1:76-86.

Sharma A. Global research priorities for non-communicable diseases prevention, management, and control. Int J Non-Commun Dis. 2017;2:107-12

Kathirvel S, Thakur Rapporteurs JS. Sustainable development goals and non-communicable diseases: Roadmap till 2030 - A plenary session of world non communicable diseases congress 2017. Int J non-Commun Dis. 2018;3:3-8.

Mahipala P, Dorji G, Tisocki K, Rani M. A critical review of addressing cardiovascular and other non-communicable diseases through a primary health care approach in the South-East Asia Region. Cardiovasc Diagn Ther. 2019;9(2):150-7.

Tripathy JP. Partnerships in non-communicable disease prevention and control. Int J Non-Commun Dis. 2017;2:102-6.

Low W, Lee Y, Samy AL. Non-communicable diseases in the Asia-Pacific region: prevalence, risk factors and community-based prevention. Int J Occup Med Environ Health. 2015;28(1):20-6.

Doubeni CA, Gabler NB, Wheeler CM, McCarthy AM, Castle PE, Halm EA. Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium. CA Cancer J Clin. 2018;68(3):199-216.

SaeiGhareNaz M, Simbar M, RashidiFakari F, Ghasemi V. Effects of model-based interventions on breast cancer screening behavior of women: a systematic review. Asian Pac J Cancer Prev. 2018;19(8):2031-41.

Christe DM, Chandrasekar A, Jayashree K, Meenalochani P, Gunasingh STK. Prevention of cervical cancer: early detection of precancerous lesions of cervix in women from a marginalized environment. Int J Reprod Contracept Obstet Gynecol. 2018;7(12):5156-61.

Christe DM, Kanchana MP. Impact of cervical cancer screening in a referral centre. J Pharm Biomed Sci. 2016;06(06):360-2.

Christe DM, Kanchana MP, Sheelaa W. Recent changes in incidence of cervical cancer in a gynecologic cancer treatment center Chennai, India. J Hosp Pharma. 2019;14:4.

Christe DM, Mohanambal M, Ramamoorthy V, Snehaa NB. A study of cervical cancer screening for prevention of carcinoma cervix. J Indian Med Assoc. 2008;106(12):779-82.

Srivastava AN, Misra JS, Srivastava S, Das BC, Gupta S. Cervical cancer screening in rural India: Status and current concepts. Indian J Med Res. 2018;148(6):687-96.

Sauvaget C, Fayette JM, Muwonge R, Wesley R, Sankaranarayanan R. Accuracy of visual inspection with acetic acid for cervical cancer screening. Inter J Gynecol Obstet. 2011;113:14-24.

Gaffney DK, Hashibe M, Kepka D, Maurer KA, Werner TL. Too many women are dying from cervix cancer: problems and solutions. Gynecol Oncol. 2018;151(3):547-54.

Yang H, Zhang X, Hao Z. The diagnostic accuracy of a real-time optoelectronic device in cervical cancer screening: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2018;97(29):e11439.

Dillner J. Early detection and prevention. Mol Oncol. 2019;13(3):591-8.